Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation.

about

Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation.

Item

http://www.wikidata.org/entity/Q38674466

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Rabbit anti-human thymocyte im ...... iatric kidney transplantation.

@en

type

Item

label

Rabbit anti-human thymocyte im ...... iatric kidney transplantation.

@en

prefLabel

Rabbit anti-human thymocyte im ...... iatric kidney transplantation.

@en

P1476

Rabbit anti-human thymocyte im ...... iatric kidney transplantation.

@en

P2093

Christian Lerch

http://www.w3.org/2001/XMLSchema#string

Imke Hennies

http://www.w3.org/2001/XMLSchema#string

Jens Drube

http://www.w3.org/2001/XMLSchema#string

Kerstin Froede

http://www.w3.org/2001/XMLSchema#string

Lars Pape

http://www.w3.org/2001/XMLSchema#string

Martin Kreuzer

http://www.w3.org/2001/XMLSchema#string

Murielle Verboom

http://www.w3.org/2001/XMLSchema#string

Nele Kanzelmeyer

http://www.w3.org/2001/XMLSchema#string

Thurid Ahlenstiel-Grunow

http://www.w3.org/2001/XMLSchema#string

Yasemen Cihan

http://www.w3.org/2001/XMLSchema#string

P2860

New equations to estimate GFR in children with CKD

Rabbit antithymocyte globulin and donor-specific antibodies in kidney transplantation--A review

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients

New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity

Proteasome inhibitor-based therapy for antibody-mediated rejection

Immune reconstitution following rabbit antithymocyte globulin.

Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients

Pediatric kidney transplantation followed by de novo therapy with everolimus, low-dose cyclosporine A, and steroid elimination: 3-year data.

Diagnosis and management of antibody-mediated rejection: current status and novel approaches.

A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation.

P2888

s00467-017-3725-1

P31

scholarly article

P356

10.1007/S00467-017-3725-1

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090742691

http://www.w3.org/2001/XMLSchema#string

P698

28717935

http://www.w3.org/2001/XMLSchema#string